Collection efficiency on the fenwal CS3000 when using filgrastim (recombinant methionyl human granulocyte colony-stimulating factor) as a peripheral blood stem cell mobilization agent

The collection efficiency (CE) of the Fenwal CS3000 in collecting peripheral blood stem cells during post‐chemotherapy recovery phase ranges from 58% to 73%. Recently filgrastim (recombinant methionyl human granulocyte colony‐stimulating factor [G‐CSF]) has also been shown to be effective as a mobil...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical apheresis 1994, Vol.9 (1), p.17-20
Hauptverfasser:	To, L. Bik, Stemmelin, German R., Haylock, David N., Bayly, Joanne L., Thorp, Dawn, Rawling, Caroline M., Trimboli, Sandra, Juttner, Christopher A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Bone marrow, stem cells transplantation. Graft versus host reaction collection efficiency Female Filgrastim G-CSF Granulocyte Colony-Stimulating Factor - pharmacology Hematopoietic Stem Cells - cytology Humans leukapheresis Leukapheresis - methods Male Medical sciences Middle Aged peripheral blood stem cells Recombinant Proteins - pharmacology Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!